I’m sorry to hear your CPAP mask is keeping you awake at night, but I’m happy to hear that you’re addressing your obstructive ...

LivaNova today announced that its OSPREY trial of nerve stimulation for treating sleep apnea met its primary endpoints.

Livanova said Monday a trial of its obstructive sleep apnea (OSA) implant met its primary safety and efficacy endpoints, positioning the company to seek approval once the analysis is complete. The ...

"If you have obstructive sleep apnea, yes, this can be very dangerous." "There is limited evidence on the benefits of mouth taping and I would be very careful — and even talk to your health care ...

Doctor Viorrito says, “Sleep apnea, especially in our school aged children can look exactly like ADHD.” A report from the ...

Central sleep apnea occurs when there is an issue with the central nervous system. In contrast, obstructive sleep apnea occurs when part or all of the upper airway collapses during sleep.

LITTLETON, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development ...

Researchers released new clinical guidelines for treating restless legs syndrome (RLS), emphasizing patient-centered care and ...

Obstructive sleep apnea occurs when the upper airway patency is restricted or collapses during inspiration. Such collapse is a dynamic process that involves interactions between sleep state ...

LivaNova met the primary endpoints for its OSPREY trial, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation.

Background: The strength of the association between obstructive sleep apnea-hypopnea syndrome (OSAHS) and systemic hypertension could be affected by methodologic problems in the definition of ...

LivaNova (LIVN) “announced that it met the primary endpoints for its OSPREY randomized controlled trial, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation. Together with ...